173 related articles for article (PubMed ID: 22046025)
1. Identification and elucidation of the biology of adverse events: the challenges of safety assessment and translational medicine.
Turteltaub KW; Davis MA; Burns-Naas LA; Lawton MP; Clark AM; Reynolds JA
Clin Cancer Res; 2011 Nov; 17(21):6641-5. PubMed ID: 22046025
[TBL] [Abstract][Full Text] [Related]
2. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
3. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
EFSA GMO Panel Working Group on Animal Feeding Trials
Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
[TBL] [Abstract][Full Text] [Related]
4. Translational bioinformatics and systems biology approaches for personalized medicine.
Yan Q
Methods Mol Biol; 2010; 662():167-78. PubMed ID: 20824471
[TBL] [Abstract][Full Text] [Related]
5. Application of genomics in preclinical drug safety evaluation.
Lord PG; Nie A; McMillian M
Basic Clin Pharmacol Toxicol; 2006 Jun; 98(6):537-46. PubMed ID: 16700814
[TBL] [Abstract][Full Text] [Related]
6. Systems biology in drug discovery.
Butcher EC; Berg EL; Kunkel EJ
Nat Biotechnol; 2004 Oct; 22(10):1253-9. PubMed ID: 15470465
[TBL] [Abstract][Full Text] [Related]
7. The application of systems biology to drug discovery.
Cho CR; Labow M; Reinhardt M; van Oostrum J; Peitsch MC
Curr Opin Chem Biol; 2006 Aug; 10(4):294-302. PubMed ID: 16822703
[TBL] [Abstract][Full Text] [Related]
8. Where are we in genomics?
Hocquette JF
J Physiol Pharmacol; 2005 Jun; 56 Suppl 3():37-70. PubMed ID: 16077195
[TBL] [Abstract][Full Text] [Related]
9. [Application of systems biology method in the research of traditional Chinese medicine].
Li P; Yang LP
Zhong Xi Yi Jie He Xue Bao; 2008 May; 6(5):454-7. PubMed ID: 18471406
[TBL] [Abstract][Full Text] [Related]
10. Risk management frameworks for human health and environmental risks.
Jardine C; Hrudey S; Shortreed J; Craig L; Krewski D; Furgal C; McColl S
J Toxicol Environ Health B Crit Rev; 2003; 6(6):569-720. PubMed ID: 14698953
[TBL] [Abstract][Full Text] [Related]
11. Systems biology and theranostic approach to drug discovery and development to treat traumatic brain injury.
Zhang Z; Larner SF; Kobeissy F; Hayes RL; Wang KK
Methods Mol Biol; 2010; 662():317-29. PubMed ID: 20824479
[TBL] [Abstract][Full Text] [Related]
12. Quantitative proteomics for drug toxicity.
Gao Y; Holland RD; Yu LR
Brief Funct Genomic Proteomic; 2009 Mar; 8(2):158-66. PubMed ID: 19351682
[TBL] [Abstract][Full Text] [Related]
13. [Use of translational medicine in the early diagnosis of xenobiotic-induced intrauterine growth retardation].
Liu YS; Wang H
Yao Xue Xue Bao; 2011 Jan; 46(1):30-4. PubMed ID: 21465805
[TBL] [Abstract][Full Text] [Related]
14. Computational toxicology as implemented by the U.S. EPA: providing high throughput decision support tools for screening and assessing chemical exposure, hazard and risk.
Kavlock R; Dix D
J Toxicol Environ Health B Crit Rev; 2010 Feb; 13(2-4):197-217. PubMed ID: 20574897
[TBL] [Abstract][Full Text] [Related]
15. The art and practice of systems biology in medicine: mapping patterns of relationships.
van der Greef J; Martin S; Juhasz P; Adourian A; Plasterer T; Verheij ER; McBurney RN
J Proteome Res; 2007 Apr; 6(4):1540-59. PubMed ID: 17373844
[TBL] [Abstract][Full Text] [Related]
16. Metabolomics in cancer: a bench-to-bedside intersection.
Claudino WM; Goncalves PH; di Leo A; Philip PA; Sarkar FH
Crit Rev Oncol Hematol; 2012 Oct; 84(1):1-7. PubMed ID: 22429650
[TBL] [Abstract][Full Text] [Related]
17. Systems toxicology: applications of toxicogenomics, transcriptomics, proteomics and metabolomics in toxicology.
Heijne WH; Kienhuis AS; van Ommen B; Stierum RH; Groten JP
Expert Rev Proteomics; 2005 Oct; 2(5):767-80. PubMed ID: 16209655
[TBL] [Abstract][Full Text] [Related]
18. Towards quantitative biology: integration of biological information to elucidate disease pathways and to guide drug discovery.
Fischer HP
Biotechnol Annu Rev; 2005; 11():1-68. PubMed ID: 16216773
[TBL] [Abstract][Full Text] [Related]
19. New science-based endpoints to accelerate oncology drug development.
Kelloff GJ; Sigman CC
Eur J Cancer; 2005 Mar; 41(4):491-501. PubMed ID: 15737552
[TBL] [Abstract][Full Text] [Related]
20. Current challenges in the evaluation of cardiac safety during drug development: translational medicine meets the Critical Path Initiative.
Piccini JP; Whellan DJ; Berridge BR; Finkle JK; Pettit SD; Stockbridge N; Valentin JP; Vargas HM; Krucoff MW;
Am Heart J; 2009 Sep; 158(3):317-26. PubMed ID: 19699852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
